查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538448

医药级磷脂市场报告：2030 年趋势、预测与竞争分析

Pharmaceutical Grade Phospholipid Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

医药级磷脂的趋势与预测

2024年至2030年，全球医药级磷脂市场预计将以4.4%的复合年增长率成长。该市场的主要驱动因素是对基于脂质的药物传输系统的需求不断增长、药物製剂中磷脂的使用不断增加以及对药物生物有效性和药物稳定性的日益关注。由于製药和医疗市场的机会，全球医药级磷脂市场的未来前景看好。

医药级磷脂依细分市场划分

该研究包括按类型、应用和地区分類的全球医药级磷脂的预测。

医药级磷脂市场洞察

Lucintel 预测天然磷脂会有更高的成长。

在这个市场中，药品预计将呈现更高的成长。

亚太地区预计成长最快。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球医药级磷脂市场预计将以4.4%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动因素是对基于脂质的药物传输系统的需求不断增长、药物製剂中磷脂的使用不断增加以及对药物生物有效性和药物稳定性的日益关注。

Q3.市场的主要细分市场是：

A3. 由于医药和医疗市场的机会，医药级磷脂市场的未来性广阔。

Q4.市场的主要企业是：

A4. 生产医药级磷脂质的主要企业如下：

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm

Q5.未来最大的细分市场是什么？

A5.Lucintel 预测天然磷脂的成长速度较快。

Q6.未来五年预计哪些地区的市场成长最大？

A6.亚太地区预计成长最快。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球药用级磷脂市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球药用级磷脂市场趋势（2018-2023）与预测（2024-2030）
  • 全球药用级磷脂市场（按类型）
    • 天然磷脂
    • 合成磷脂
  • 全球药用级磷脂市场（按应用）
    • 药品
    • 医疗保健
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球药用级磷脂市场（按地区）
  • 北美药用级磷脂市场
  • 欧洲医药级磷脂市场
  • 亚太地区药用级磷脂市场
  • 其他地区药用级磷脂市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球药用级磷脂市场的成长机会（按类型）
    • 全球药用级磷脂市场成长机会（按应用）
    • 全球药用级磷脂市场成长机会（按地区）
  • 全球药用级磷脂市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球医药级磷脂市场产能扩张
    • 全球医药级磷脂市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm
简介目录

Pharmaceutical Grade Phospholipid Trends and Forecast

The future of the global pharmaceutical grade phospholipid market looks promising with opportunities in the pharmaceutical and healthcare markets. The global pharmaceutical grade phospholipid market is expected to grow with a CAGR of 4.4% from 2024 to 2030. The major drivers for this market are rising demand for lipid-based drug delivery systems, increasing adoption of phospholipids in pharmaceutical formulations, and growing focus on bioavailability & drug stability in pharmaceutical products.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Pharmaceutical Grade Phospholipid by Segment

The study includes a forecast for the global pharmaceutical grade phospholipid by type, application, and region.

Pharmaceutical Grade Phospholipid Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Natural Phospholipids
  • Synthetic Phospholipids

Pharmaceutical Grade Phospholipid Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceuticals
  • Healthcare
  • Others

Pharmaceutical Grade Phospholipid Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pharmaceutical Grade Phospholipid Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical grade phospholipid companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical grade phospholipid companies profiled in this report include-

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm

Pharmaceutical Grade Phospholipid Market Insights

Lucintel forecasts that natural phospholipid is expected to witness higher growth.

Within this market, pharmaceutical is expected to witness higher growth.

APAC is expected to witness the highest growth.

Features of the Global Pharmaceutical Grade Phospholipid Market

Market Size Estimates: Pharmaceutical grade phospholipid market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pharmaceutical grade phospholipid market size by type, application, and region in terms of value ($B).

Regional Analysis: Pharmaceutical grade phospholipid market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the pharmaceutical grade phospholipid market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pharmaceutical grade phospholipid market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for pharmaceutical grade phospholipid market?

Answer: The global pharmaceutical grade phospholipid market is expected to grow with a CAGR of 4.4% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the pharmaceutical grade phospholipid market?

Answer: The major drivers for this market are rising demand for lipid-based drug delivery systems, increasing adoption of phospholipids in pharmaceutical formulations, and growing focus on bioavailability & drug stability in pharmaceutical products.

Q3. What are the major segments for pharmaceutical grade phospholipid market?

Answer: The future of the pharmaceutical grade phospholipid market looks promising with opportunities in the pharmaceutical and healthcare markets.

Q4. Who are the key pharmaceutical grade phospholipid market companies?

Answer: Some of the key pharmaceutical grade phospholipid companies are as follows:

  • Cargill Incorporated
  • Avril
  • Sime Darby Oils
  • Croda Pharma
  • Nippon Fine Chemical
  • Nof Corporation
  • Suzhou Fushilai Pharmaceutical
  • LIPOID
  • Louis Dreyfus Company
  • Shenyang Tianfeng Bio-Pharm

Q5. Which pharmaceutical grade phospholipid market segment will be the largest in future?

Answer: Lucintel forecasts that natural phospholipid is expected to witness higher growth.

Q6. In pharmaceutical grade phospholipid market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical grade phospholipid market by type (natural phospholipids and synthetic phospholipids), application (pharmaceuticals, healthcare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pharmaceutical Grade Phospholipid Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pharmaceutical Grade Phospholipid Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pharmaceutical Grade Phospholipid Market by Type
    • 3.3.1: Natural Phospholipids
    • 3.3.2: Synthetic Phospholipids
  • 3.4: Global Pharmaceutical Grade Phospholipid Market by Application
    • 3.4.1: Pharmaceuticals
    • 3.4.2: Healthcare
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pharmaceutical Grade Phospholipid Market by Region
  • 4.2: North American Pharmaceutical Grade Phospholipid Market
    • 4.2.1: North American Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.2.2: North American Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
  • 4.3: European Pharmaceutical Grade Phospholipid Market
    • 4.3.1: European Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.3.2: European Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
  • 4.4: APAC Pharmaceutical Grade Phospholipid Market
    • 4.4.1: APAC Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.4.2: APAC Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others
  • 4.5: ROW Pharmaceutical Grade Phospholipid Market
    • 4.5.1: ROW Pharmaceutical Grade Phospholipid Market by Type: Natural Phospholipids and Synthetic Phospholipids
    • 4.5.2: ROW Pharmaceutical Grade Phospholipid Market by Application: Pharmaceuticals, Healthcare, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pharmaceutical Grade Phospholipid Market by Type
    • 6.1.2: Growth Opportunities for the Global Pharmaceutical Grade Phospholipid Market by Application
    • 6.1.3: Growth Opportunities for the Global Pharmaceutical Grade Phospholipid Market by Region
  • 6.2: Emerging Trends in the Global Pharmaceutical Grade Phospholipid Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pharmaceutical Grade Phospholipid Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmaceutical Grade Phospholipid Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Cargill Incorporated
  • 7.2: Avril
  • 7.3: Sime Darby Oils
  • 7.4: Croda Pharma
  • 7.5: Nippon Fine Chemical
  • 7.6: Nof Corporation
  • 7.7: Suzhou Fushilai Pharmaceutical
  • 7.8: LIPOID
  • 7.9: Louis Dreyfus Company
  • 7.10: Shenyang Tianfeng Bio-Pharm